AT7519 TFA
AT7519 is a potent, multi-target cyclin-dependent kinase (CDK) inhibitor with IC50 values ranging from 0.018 to 0.66 μM against CDK1, CDK2, CDK4, CDK5, and CDK6. It is widely used in cancer research to study cell cycle arrest and apoptosis, demonstrating antitumor activity in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1431697-85-6
Field of Research
Cell Biology, Immunology & Inflammation
Smiles
OC (=O) C (F) (F) F.Clc1cccc (Cl) c1C (=O) Nc1c[nH]nc1C (=O) NC1CCNCC1
Molecular Formula
C18H18Cl2F3N5O4
Molecular Weight
496.27
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1022697-01 0.05 mg (E-Coli)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details 
MBS1022697-02 0.2 mg (E-Coli)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details 
MBS1022697-03 0.5 mg (E-Coli)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details MBS1022697-04 0.05 mg (Yeast)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details 
MBS1022697-05 0.05 mg (Baculovirus)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details MBS1022697-06 0.2 mg (Yeast)
Recombinant Phyllomedusa sauvagei Phyllokinin
Sign In for Pricing
View Details